Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines

ASEM documentary overview

Official National Advisory Committee on Immunization document (2020) on “Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines”. Flucelvax® Quad is a mammalian cell culture-based, inactivated seasonal influenza vaccine that has recently been authorized for use in Canada in adults and children ≥9 years of age.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.